Markets Overview

The S&P 500 (^GSPC) continues to trade near record highs, up 6% year to date, powered by strong earnings growth — but cracks may be forming beneath the surface. Wells Fargo strategists are flashing the first sell signal for stocks since 2021, warning that the "sugar high" driving markets higher has run its course and key tailwinds are now exhausted.

Oil futures cratered 8% after reports that the U.S. and Iran are in talks on a memo to end hostilities, with President Trump pausing efforts to partially reopen the Strait of Hormuz to buy time for a broader agreement. The move marks a sharp de-escalation premium being pulled from energy markets.

Globally, South Korea's Kospi is the world's hottest market, surging 75% this year as Samsung Electronics (005930.KS) reached a $1 trillion market cap. The index has now leapfrogged Canada in global rankings, driven by heavier tech representation and exposure to emerging industries. Meanwhile, top-performing Nasdaq stocks are exhibiting concentration dynamics that rival — or exceed — the peak of the dot-com bubble, a comparison that should give semiconductor bulls pause.

Earnings Reports

Disney (DIS) shares rose after the first earnings report under new CEO Josh D'Amaro, which showed the theme-park business remains healthy and guided for 12% EPS growth for the full year. The report signals a smooth leadership transition and resilient consumer spending on experiences.

Meta Platforms (META) posted headline Q1 numbers that looked spectacular — revenue jumped 33% YoY to $56.3 billion, accelerating from 24% prior — but investors should look under the hood. A major tax benefit flattered GAAP earnings, and the adjusted figures tell a more nuanced story.

DoorDash (DASH) stock soared in premarket despite mixed results and guidance that didn't blow away expectations. The market appears to be rewarding the company's execution trajectory over near-term numbers.

Novo Nordisk (NVO) reported the fastest take-up in weight-loss drug history for its Wegovy pill but only narrowly lifted full-year guidance, still projecting profit and sales declines for the year — a disconnect that underscores the gap between blockbuster adoption and near-term financials.

DuPont (DD) ripped over 9% on a convincing beat-and-raise quarter. Insmed (INSM) beat on both lines, with EPS of -$0.76 topping estimates by $0.22 on revenue of $306M ($5.2M beat). Kimbell Royalty Partners (KRP) was the notable miss, with EPS of $0.04 falling $0.21 short and revenue of $65.5M missing by $24.2M. Akebia (AKBA) posted in-line EPS of -$0.03 with a modest $1.8M revenue beat.

Fed & Economic Data

Citadel's Ken Griffin sounded an inflation warning that Wall Street won't want to hear, even as the S&P 500 and Nasdaq Composite push toward new highs. The comments come amid growing unease about the macro backdrop in "President Trump's economy."

Markets are also looking ahead to a potential Fed leadership change, with Kevin Warsh reportedly in line to replace Jerome Powell. The transition could introduce policy uncertainty into a market that has more than doubled since the October 2022 bull market began. Separately, institutional money is rotating defensively — IFC Advisors added $4.5 million to the Angel Oak UltraShort Income ETF (UYLD), increasing its stake by nearly 89,000 shares in Q1.

Hot Sectors

Semiconductors are seeing selling pressure ease after a volatile stretch driven by massive 2026 capex commitments from Amazon, Alphabet, and Meta for AI infrastructure buildout. The VanEck Semiconductor ETF (SMH) is being watched as a potential rebound vehicle, though dot-com-era comparisons in the sector linger.

Obesity/GLP-1 drugs remain a dominant theme. Novo Nordisk's Wegovy pill launch is setting records, and the two-horse race between Novo and Eli Lilly continues to define the space for investors seeking exposure.

Rare earths and reshoring are in focus as MP Materials (MP), the only fully integrated U.S. rare earth producer, has rallied 30%+ this year on deals with Apple and the Pentagon — though profitability remains years away.

Private credit is showing stress: two Blue Owl Capital funds cut their dividends, with one having sold half its SpaceX stake before the IPO.

Stock News

Intel (INTC) is up a staggering 170% in 2026 after the U.S. government took a nearly 10% stake in the company, backing its advanced chip manufacturing push. The comeback raises the question of whether the rally has outrun fundamentals.

Pfizer (PFE) silenced dividend skeptics — management reaffirmed the 6.5% forward yield, the highest among large-cap healthcare stocks, easing fears of a cut. UnitedHealth (UNH) management is increasing buybacks, signaling they view shares as undervalued by multiple metrics.

Maersk warned that the Iran war's impact on shipping will intensify in coming months, with customers facing price hikes even as oil prices fell sharply on peace talk reports — a reminder that supply-chain disruptions lag geopolitical headlines.

Market Analysis

The macro picture is increasingly bifurcated: record-high indices and strong earnings coexist with an inflation warning from one of the world's most prominent hedge fund managers, a first-sell-signal-since-2021 call from Wells Fargo, and dot-com-era concentration in top Nasdaq performers. The 8% oil plunge on Iran diplomacy news could relieve inflation pressure if sustained, but Maersk's warning suggests shipping costs won't normalize quickly.

Watch tomorrow: The Fed leadership transition narrative around Kevin Warsh is gaining momentum and could become a volatility catalyst. Earnings season continues with results trickling in across sectors. And the Iran situation bears close monitoring — if talks produce a formal memo, expect further energy repricing and a potential rotation out of defense names. Samsung's $1 trillion milestone and South Korea's remarkable run highlight a broadening of global tech leadership beyond U.S. mega-caps — a trend worth tracking as portfolio diversification gains appeal.